TLDC2
Basic information
Region (hg38): 20:36876121-36894235
Previous symbols: [ "C20orf118" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TLDC2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 13 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 23 | 25 | 54 | |||
Total | 0 | 0 | 36 | 29 | 8 |
Variants in TLDC2
This is a list of pathogenic ClinVar variants found in the TLDC2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-36877933-A-T | not specified | Uncertain significance (Jul 19, 2022) | ||
20-36877940-C-G | not specified | Uncertain significance (Jan 04, 2024) | ||
20-36877996-C-G | not specified | Uncertain significance (Oct 05, 2023) | ||
20-36878008-A-G | not specified | Uncertain significance (Nov 10, 2022) | ||
20-36878013-A-G | not specified | Likely benign (Nov 18, 2022) | ||
20-36878047-T-C | not specified | Uncertain significance (Oct 29, 2021) | ||
20-36878049-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
20-36879069-C-T | not specified | Uncertain significance (Oct 03, 2023) | ||
20-36879096-G-T | not specified | Uncertain significance (Sep 20, 2023) | ||
20-36879117-G-A | not specified | Uncertain significance (Oct 06, 2022) | ||
20-36879123-A-T | not specified | Uncertain significance (May 31, 2023) | ||
20-36879138-G-A | not specified | Likely benign (Oct 26, 2022) | ||
20-36879145-G-C | Likely benign (Nov 01, 2022) | |||
20-36879155-G-A | Benign (Jun 01, 2018) | |||
20-36879188-G-A | not specified | Uncertain significance (Nov 03, 2023) | ||
20-36879189-G-A | not specified | Uncertain significance (Jan 30, 2024) | ||
20-36880665-C-G | not specified | Uncertain significance (Dec 09, 2023) | ||
20-36889299-C-A | Likely benign (Nov 01, 2022) | |||
20-36891924-G-C | Chilblain lupus 2 • Aicardi-Goutieres syndrome 5 | Benign (Jan 12, 2018) | ||
20-36892050-A-G | Aicardi-Goutieres syndrome 5 • Chilblain lupus 2 | Uncertain significance (Jan 12, 2018) | ||
20-36892061-C-T | Aicardi-Goutieres syndrome 5 • Chilblain lupus 2 | Uncertain significance (Jan 12, 2018) | ||
20-36892215-C-G | Aicardi-Goutieres syndrome 5 • Chilblain lupus 2 | Uncertain significance (Jan 12, 2018) | ||
20-36892221-T-G | Chilblain lupus 2 • Aicardi-Goutieres syndrome 5 | Uncertain significance (Jan 13, 2018) | ||
20-36892284-G-A | Chilblain lupus 2 • Aicardi-Goutieres syndrome 5 | Uncertain significance (Feb 16, 2018) | ||
20-36892303-G-A | Aicardi-Goutieres syndrome 5 • Chilblain lupus 2 | Benign (Jan 12, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TLDC2 | protein_coding | protein_coding | ENST00000217320 | 6 | 18115 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0165 | 0.962 | 125719 | 0 | 29 | 125748 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.297 | 142 | 132 | 1.07 | 0.00000803 | 1395 |
Missense in Polyphen | 49 | 47.843 | 1.0242 | 568 | ||
Synonymous | 0.214 | 52 | 54.0 | 0.963 | 0.00000340 | 425 |
Loss of Function | 2.01 | 5 | 12.7 | 0.393 | 6.30e-7 | 130 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000297 | 0.000297 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000141 | 0.000123 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
Intolerance Scores
- loftool
- rvis_EVS
- 0.48
- rvis_percentile_EVS
- 79.25
Haploinsufficiency Scores
- pHI
- 0.153
- hipred
- N
- hipred_score
- 0.199
- ghis
- 0.415
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tldc2
- Phenotype